Anatoly Dritschilo MD FACR
Breast Cancer, Head & Neck, Skin Cancer
Professor of Medicine, Georgetown University
Join to View Full Profile
3800 Reservoir Rd NwWashington, DC 20007
Phone+1 202-444-3320
Dr. Dritschilo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anatoly Dritschilo is a radiation oncologist based in Washington, DC, specializing in breast cancer, prostate cancer, and central nervous system tumors. He completed his residency in radiation oncology at the Brigham and Women's Hospital/Joint Center for Radiation Therapy and Tufts Medical Center, following his medical degree from Rutgers New Jersey Medical School. He has served as the Department Chairman at MedStar Georgetown University Hospital and has held the position of Chairman at Georgetown University School of Medicine since 1979. Dr. Dritschilo has published research on radiation resistance and immune response in cancer treatment, contributing to several peer-reviewed journals. He has been recognized by Castle Connolly as one of America's Top Doctors and Top Doctors for Cancer. He has engaged in clinical trial research focused on advanced malignancies and currently serves as the CEO of Prostate Theranostics, Inc., a discover Pharma Biotech.
Education & Training
Tufts Medical CenterResidency, Radiation Oncology, 1977 - 1977
Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1974 - 1977
University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1973 - 1974
Rutgers New Jersey Medical SchoolClass of 1973
Certifications & Licensure
DC State Medical License 1979 - 2024
MD State Medical License 1980 - 2024
VA State Medical License 1997 - 2018
American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Top Doctors:Washington DC Area Castle Connolly, 2012
Clinical Trials
- Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies Start of enrollment: 2001 Mar 01
Publications & Presentations
PubMed
- 1 citationsProton-boron capture interaction enhances killing of radiation resistant cancer cells.Dalong Pang, Mira Jung, Alfredo Velena, William Parke, Anatoly Dritschilo
Frontiers in Oncology. 2025-01-01 - 18 citationsCell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma.Satish Kumar Reddy Noonepalle, Maria Gracia-Hernandez, Nima Aghdam, Michael Berrigan, Hawa Coulibaly
Journal of Experimental & Clinical Cancer Research. 2024-09-14 - 2 citationsDual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth.Mira Jung, Nicole Nicholas, Scott Grindrod, Anatoly Dritschilo
Plos One. 2024-01-01
Press Mentions
Shuttle Pharma Provides Corporate UpdateMay 15th, 2025- Shuttle Pharmaceuticals Hits Milestone in Patient Enrollment for Phase 2 Clinical TrialJanuary 22nd, 2025
- Shuttle Pharmaceuticals Holdings, Inc. Finalizes Agreements for Phase 2 Clinical Trial Enrollment: Press Release AnalysisOctober 30th, 2024
Grant Support
- Mechanisms Of Cellular Responses To Ionizing RadiationNational Cancer Institute1997–2006
- Cancer Center Support GrantNational Cancer Institute2005
- Georgetown University AP4 Center PLANNational Cancer Institute2004
- Radiosensitization Of Pancreatic Cancers Through RAF-1National Cancer Institute2002
- Molecular Studies Of Radiation Resistant Tumor CellsNational Cancer Institute1997–2001
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
